197.80p+2.10 (+1.07%)16 Sep 2021, 16:29
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Indivior PLC Fundamentals

Company NameIndivior PLCLast Updated2021-09-16
IndustryDrug Manufacturers - Specialty & GenericSectorHealthcare
Shares in Issue726.376 mMarket Cap£1.44 bn
PE Ratio15.02Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-$0.20EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.1735Debt Equity Ratio1.1974
Asset Equity Ratio7.1717Cash Equity Ratio4.2918
Quick Ratio1.8483Current Ratio2.04
Price To Book Value8.4246ROCE0

Indivior PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Indivior PLC Company Financials

Tangible Assets$103.00 m$107.00 m$57.00 m
Intangible Assets$62.00 m$72.00 m$84.00 m
Total Fixed Assets$344.00 m$292.00 m$218.00 m
Stocks$93.00 m$73.00 m$78.00 m
Debtors$179.00 m$192.00 m$278.00 m
Cash & Equivalents$858.00 m$1.06 bn$924.00 m
Other Assets000
Total Assets$1.53 bn$1.65 bn$1.55 bn
Creditors within 1 year$599.00 m$742.00 m$818.00 m
Creditors after 1 year$850.00 m$701.00 m$663.00 m
Other Liabilities000
Total Liabilities$1.45 bn$1.44 bn$1.48 bn
Net assets$82.00 m$209.00 m$66.00 m
Called up share capital$73.00 m$73.00 m$73.00 m
Share Premium$6.00 m$5.00 m$5.00 m
Profit / Loss-$173.00 m$180.00 m$278.00 m
Other Equity$82.00 m$209.00 m$66.00 m
Preference & Minorities000
Total Capital Employed$82.00 m$209.00 m$66.00 m
Debt Ratio$0.77$0.58$0.78
Assets / Equity7.17177.17177.1717
Cash / Equity4.29184.29184.2918
Cash Flow202020192018
Cash from operating activities-$193.00 m$151.00 m$303.00 m
Cashflow before financing-$203.00 m$138.00 m$66.00 m
Increase in Cash-$207.00 m$136.00 m$62.00 m
Turnover$647.00 m$785.00 m$1.00 bn
Cost of sales$97.00 m$140.00 m$128.00 m
Gross Profit$550.00 m$645.00 m$877.00 m
Operating Profit-$156.00 m$178.00 m$292.00 m
Pre-Tax profit-$173.00 m$180.00 m$278.00 m

Indivior PLC Company Background

ActivitiesIndivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Latest Interim Date29 Jul 2021
Latest Fiscal Year End Date18 Feb 2021

Indivior PLC Directors

2018-03-22Mr. Cary J ClaiborneExecutive Director,Chief Financial Officer
2019-07-31Mr. Christian Stanton SchadeNon-Executive Director
2019-08-29Ms. Lizabeth Herbst ZlatkusNon-Executive Director
2019-03-29Dr. Yvonne L GreenstreetNon-Executive Director
2020-09-04Mr. Howard Hao PienNon-Executive Director,Chairman
2016-05-11Mr. Adrian Nevil Hennah Non-Executive Director
2021-08-05Mr. Graham Charles HetheringtonNon-Executive Director,Chairman
2016-10-03Mr. Rupert Mark Boden BondyNon-Executive Director
2020-07-31Ms. Tatjana Anni Hilde MayNon-Executive Director
2021-03-31Mr. Daniel Joseph PhelanNon-Executive Director
2021-08-11Mr. Mark StejbachNon-Executive Director
2021-03-31Dr. Peter James Jonathan Bains Non-Executive Director
2021-08-10Mr. Jerome J LandeNon-Executive Director
2021-03-31Ms. Lorna Mary Southcombe ParkerNon-Executive Director
2021-01-11Mr. Daniel TasseNon-Executive Director,Senior Independent Director
2020-06-29Mr. Shaun ThaxterExecutive Director,Chief Executive Officer
2021-03-31Dr. Andrew Thomas McLellanNon-Executive Director
2021-03-31Mr. Mark Wesley CrossleyExecutive Director,Chief Executive Officer
2021-03-31Mr. Ryan PreblickExecutive Director,Chief Financial Officer

Indivior PLC Contact Details

Company NameIndivior PLC
Address234 Bath Road, Slough, SL1 4EE
Telephone+44 1753217800

Indivior PLC Advisors

Remuneration ConsultantWillis Towers Watson
Phone+44 2071702000
Fax+44 2071702222
SolicitorHerbert Smith Freehills LLP
Phone+44 2073748000
Fax+44 2073740888
Financial PR AdviserTulchan Communications LLP
Phone+44 2073534200
Fax+44 2073534201
Remuneration ConsultantDeloitte LLP
Phone+44 2079363000
Fax+44 2075831198
StockbrokerMorgan Stanley & Co International PLC
Phone+44 2074258000
Fax+44 2074258990
StockbrokerJefferies Hoare Govett
Phone+44 2070298000
Fax+44 2070298010
Financial AdviserJefferies Hoare Govett
Phone+44 2070298000
Fax+44 2070298010
AuditorPricewaterhouseCoopers LLP
Phone+44 2075835000
Fax+44 2078224652
SolicitorSlaughter and May
Phone+44 2076001200
Fax+44 2070905000
RegistrarComputershare Investor Services PLC
Phone+44 3707020003
Fax+44 3707036101
SolicitorCovington & Burling LLP
Phone+44 2070672000
Fax +44 2070672222